2-Amino-6-fluoro-N-phenylbenzamide | CAS:1417456-04-2

We serve 2-Amino-6-fluoro-N-phenylbenzamide CAS:1417456-04-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Amino-6-fluoro-N-phenylbenzamide

Chemical Name:2-Amino-6-fluoro-N-phenylbenzamide
CAS.NO:1417456-04-2
Synonyms:2-Amino-6-fluoro-N-phenylbenzamide
 
Physical and Chemical Properties:
Molecular Formula C13H11FN2O
Molecular Weight 230.23800
 
Specification:
Appearance:White or off-white powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Idelalisib(CAS:870281-82-6).



Contact us for information like 2-Amino-6-fluoro-N-phenylbenzamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Amino-6-fluoro-N-phenylbenzamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Amino-6-fluoro-N-phenylbenzamide Use and application,2-Amino-6-fluoro-N-phenylbenzamide technical grade,usp/ep/jp grade.


Related News: The Wuhan coronavirus has brought back memories of the 2003 outbreak of the severe acute respiratory syndrome, known as SARS, which infected more than 8,000 people and killed 774.4-(1-Acetylpiperazin-4-yl)Phenol manufacturer Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment.Methyltriacetoxysilane supplier Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment.1-Benzhydrylazetidin-3-amine vendor In the context of the new medicine policy, with the development of China’s R & D strength, the number of innovative drugs approved has been blown out, which further strengthened the demand and speed of industrialization of raw materials in China.In the context of the new medicine policy, with the development of China’s R & D strength, the number of innovative drugs approved has been blown out, which further strengthened the demand and speed of industrialization of raw materials in China.